DLL3 and small cell lung carcinoma: Taking SCLC as an example, researchers found that a minority of nonneuroendocrine SCLC cells with NOTCH activation could sustain the growth of neuroendocrine SCLC cells without NOTCH activation and exhibit cancer stem cell-like properties634, resulting in primary resistance to anti-DLL3 drugs.